[Diseases of mitochondrial DNA]
J Montoya1, A Playán, A Solano
1Departamento de Bioquímica y Biología Molecular y Celular, Universidad de Zaragoza, España. jmontoya@posta.unizar.es
Introduction:
Human diseases caused by disorders of the mitochondrial metabolism have been described more than 30 years ago. Some of these are associated to defects in the oxidative phosphorylation system (OXPHOS system), the final pathway of the mitochondrial energetic metabolism, that leads to the synthesis of ATP.
Development:
Part of the polypeptide subunits involved in the OXPHOS system are codified by the mitochondrial DNA (mtDNA). In the last 12 years, mutations (point mutations or deletions) in the mtDNA have been described and associated to well defined clinical syndromes caused by defects in the OXPHOS system. The clinical features of these diseases are very heterogeneous affecting in most cases to a great variety of organs and tissues.
Conclusions:
The correct diagnosis of these mitochondrial disorders require precise clinical, morphological, biochemical, and genetic data. The rapid advances in genetic analysis allow the rapid detection of mutations, even before the obtention of other type of analysis.
Insights
Mitochondrial DNA (mtDNA) mutations cause complex diseases linked to the oxidative phosphorylation system (OXPHOS). Genetic analysis rapidly detects these mutations, aiding diagnosis of heterogeneous mitochondrial disorders.
Area of Science:
- Biochemistry and Molecular Biology
- Genetics and Genomics
- Cellular Respiration
Context:
- Mitochondrial metabolism disorders have been recognized for over 30 years.
- Some disorders stem from defects in the oxidative phosphorylation system (OXPHOS), crucial for ATP synthesis.
- Mitochondrial DNA (mtDNA) encodes some subunits of the OXPHOS system.
Purpose:
- To highlight the association between mitochondrial DNA (mtDNA) mutations and clinical syndromes.
- To underscore the heterogeneity of clinical presentations in OXPHOS system defects.
- To emphasize the importance of integrated diagnostic approaches for mitochondrial disorders.
Summary:
- Mutations (point mutations or deletions) in mtDNA have been linked to specific clinical syndromes due to OXPHOS system defects over the past 12 years.
- These mitochondrial disorders exhibit significant clinical heterogeneity, frequently affecting multiple organs and tissues.
- Accurate diagnosis necessitates a combination of clinical, morphological, biochemical, and genetic data.
Impact:
- Advances in genetic analysis enable swift mutation detection, potentially preceding other diagnostic methods.
- Improved diagnostic capabilities facilitate earlier identification and management of mitochondrial diseases.
- Enhanced understanding of mtDNA defects contributes to the field of mitochondrial medicine and genetic diagnostics.
Related Concept Videos
Animal Mitochondrial Genetics
Mitochondria
Mitochondrial Membranes
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
ATP Synthase: Mechanism
Translocation of Proteins into the Mitochondria
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...


